Stock Track | Phreesia Soars 5.01% as Q3 Results Beat Expectations and Analysts Raise Price Targets

Stock Track

2024/12/12

Phreesia Inc. (NYSE:PHR) shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.

Analysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the company's strong revenue growth of 17% year-over-year and expectations for continued growth in the healthcare services industry.

However, some analysts highlighted risks related to Phreesia's global expansion plans, as the company may face legal hurdles and compliance costs in operating across different jurisdictions. Overall, the strong quarterly results and positive analyst commentary appear to be driving the stock's upward movement.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1188805804"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188805804\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188805804?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-12 01:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188805804","market":"hk","top_or_hot":-1,"title":"Stock Track | Phreesia Soars 5.01% as Q3 Results Beat Expectations and Analysts Raise Price Targets","media":"Stock Track","content":"<p>Phreesia Inc. (NYSE:PHR) shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.</p>\n\n<p>Analysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the company's strong revenue growth of 17% year-over-year and expectations for continued growth in the healthcare services industry.</p>\n\n<p>However, some analysts highlighted risks related to Phreesia's global expansion plans, as the company may face legal hurdles and compliance costs in operating across different jurisdictions. Overall, the strong quarterly results and positive analyst commentary appear to be driving the stock's upward movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Phreesia Soars 5.01% as Q3 Results Beat Expectations and Analysts Raise Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Phreesia Soars 5.01% as Q3 Results Beat Expectations and Analysts Raise Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-12-12 01:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Phreesia Inc. (NYSE:PHR) shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.</p>\n\n<p>Analysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the company's strong revenue growth of 17% year-over-year and expectations for continued growth in the healthcare services industry.</p>\n\n<p>However, some analysts highlighted risks related to Phreesia's global expansion plans, as the company may face legal hurdles and compliance costs in operating across different jurisdictions. Overall, the strong quarterly results and positive analyst commentary appear to be driving the stock's upward movement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHR","symbol_name":"Phreesia, Inc.","start_time":0,"source_url":"","article_id":"1188805804","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188805804","pubTimestamp":1733937987,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Phreesia Inc.  shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.Analysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the c","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PHR":"Phreesia, Inc."},"translate_title":"股票赛道Phreesia飙升5.01%，第三季度业绩超出预期且分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHR":1},"content_text":"Phreesia Inc. (NYSE:PHR) shares soared 5.01% on Wednesday during intraday trading, following the release of the company's better-than-expected third quarter fiscal 2025 results. The company reported a narrower net loss of $14.4 million, or $0.25 per share, beating analyst estimates by 11%.\nAnalysts were optimistic about Phreesia's growth prospects, with Truist raising its price target to $34 from $31 and maintaining a Buy rating. Baird also reiterated an Outperform rating on the stock. Analysts cited the company's strong revenue growth of 17% year-over-year and expectations for continued growth in the healthcare services industry.\nHowever, some analysts highlighted risks related to Phreesia's global expansion plans, as the company may face legal hurdles and compliance costs in operating across different jurisdictions. Overall, the strong quarterly results and positive analyst commentary appear to be driving the stock's upward movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}